Telephone counseling for smoking cessation

Oxford University, Department of Primary Health Care, Old Road Campus, Headington, Oxford, UK OX3 7LF.
Cochrane database of systematic reviews (Online) (Impact Factor: 6.03). 07/2006; 3(3):CD002850. DOI: 10.1002/14651858.CD002850.pub2
Source: PubMed


Smoking contributes to many health problems including cancers and heart and lung diseases. People trying to quit smoking can be helped with medication or through behavioural support such as specialist counselling and group therapy. Support, information and counselling are offered either face-to-face or by telephone. Counselling via telephone hotlines can be provided as part of a programme or separately, and can potentially reach large numbers of people. Our review of trials found telephone counselling to be effective; multiple sessions are likely to be most helpful .

Download full-text


Available from: Rafael Perera, Nov 05, 2015
  • Source
    • "Once discharged from hospital, participants in the Supported Care arm will receive up to 16 weeks of psychosocial [44] and 12 weeks of pharmacological support [12,13,45]. Psychosocial support will initially be delivered through five weekly telephone support calls, followed by 7 weeks of weekly or fortnightly telephone support calls (tailored based on participants preference), tapering to 4 weeks of fortnightly support calls between weeks 12 and 16 (Figure  1). "
    [Show abstract] [Hide abstract]
    ABSTRACT: BackgroundSmoking rates, and associated negative health outcomes, are disproportionately high among people with mental illness compared to the general population. Smoke-free policies within mental health hospitals can positively impact on patients’ motivation and self-efficacy to address their smoking. However, without post-discharge support, preadmission smoking behaviours typically resume. This protocol describes a randomised controlled trial that aims to assess the efficacy of linking mental health inpatients to community-based smoking cessation supports upon discharge as a means of reducing smoking prevalence.Methods/DesignEight hundred participants with acute mental illness will be recruited into the randomised controlled trial whilst inpatients at one of four psychiatric inpatient facilities in the state of New South Wales, Australia. After completing a baseline interview, participants will be randomly allocated to receive either: ‘Supported Care’, a multimodal smoking cessation intervention; or ‘Normal Care’, consisting of existing hospital care only. The ‘Supported Care’ intervention will consist of a brief motivational interview and a package of self-help material for abstaining from smoking whilst in hospital, and, following discharge, 16 weeks of motivational telephone-based counselling, 12 weeks of free nicotine replacement therapy, and a referral to the Quitline. Data will be collected at 1, 6 and 12 months post-discharge via computer-assisted telephone interview. The primary outcomes are abstinence from smoking (7-day point prevalence and prolonged cessation), and secondary outcomes comprise daily cigarette consumption, nicotine dependence, quit attempts, and readiness to change smoking behaviour.DiscussionIf shown to be effective, the study will provide evidence in support of systemic changes in the provision of smoking cessation care to patients following discharge from psychiatric inpatient facilities.Trial registrationAustralian New Zealand Clinical Trials Registry ANZTCN: ACTRN12612001042831. Date registered: 28 September 2012.
    Trials 07/2014; 15(1):266. DOI:10.1186/1745-6215-15-266 · 1.73 Impact Factor
  • Source
    • "The present study indicates a further improvement. Even though international comparisons are difficult due to considerable differences in treatment protocols, organization, and techniques [8,10,13], the effectiveness in the present study compares favourably with most other reports, even those including NRT [2,5,8,10,11,20-22]. The specific definition used to define the study base at the SNTQ, yet, always has to be taken into consideration when comparing results to other quitlines. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Swedish National Tobacco Quitline (SNTQ), which has both a proactive and a reactive service, has successfully provided tobacco cessation support since 1998. As there is a demand for an increase in national cessation support, and because the quitline works under funding constraints, it is crucial to identify the most clinically effective and cost-effective service. A randomized controlled trial was performed to compare the effectiveness of the high-intensity proactive service with the low-intensity reactive service at the SNTQ.
    Tobacco Induced Diseases 06/2014; 12(1):9. DOI:10.1186/1617-9625-12-9 · 1.50 Impact Factor
  • Source
    • "Most focused on a specific disease area. However, there were also reviews focusing on telehealthcare in the frail elderly [20], [21], patient satisfaction [22], [23], [24], telephone consultation [25], [26], [27], video-conferencing [28], [29], rural telehealthcare [30] and telehealthcare in Asian countries [31]. In this article, when we use the term “review” we are referring to the included 80 systematic reviews that have been quality appraised; when we discuss “studies” we are referring to the studies included within the reviews themselves. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Telehealthcare involves the use of information and communication technologies to deliver healthcare at a distance and to support patient self-management through remote monitoring and personalised feedback. It is timely to scrutinise the evidence regarding the benefits, risks and costs of telehealthcare. Two reviewers searched for relevant systematic reviews published from January 1997 to November 2011 in: The Cochrane Library, MEDLINE, EMBASE, LILACS, IndMed and PakMed. Reviewers undertook independent quality assessment of studies using the Critical Appraisal Skills Programme (CASP) tool for systematic reviews. 1,782 review articles were identified, from which 80 systematic reviews were selected for inclusion. These covered a range of telehealthcare models involving both synchronous (live) and asynchronous (store-and-forward) interactions between provider and patients. Many studies showed no differences in outcomes between telehealthcare and usual care. Several reviews highlighted the large number of short-term (<12 months) feasibility studies with under 20 participants. Effects of telehealthcare on health service indicators were reported in several reviews, particularly reduced hospitalisations. The reported clinical effectiveness of telehealthcare interventions for patients with long-term conditions appeared to be greatest in those with more severe disease at high-risk of hospitalisation and death. The failure of many studies to adequately describe the intervention makes it difficult to disentangle the contributions of technological and human/organisational factors on the outcomes reported. Evidence on the cost-effectiveness of telehealthcare remains sparse. Patient safety considerations were absent from the evaluative telehealthcare literature. Policymakers and planners need to be aware that investment in telehealthcare will not inevitably yield clinical or economic benefits. It is likely that the greatest gains will be achieved for patients at highest risk of serious outcomes. There is a need for longer-term studies in order to determine whether the benefits demonstrated in time limited trials are sustained.
    PLoS ONE 08/2013; 8(8):e71238. DOI:10.1371/journal.pone.0071238 · 3.23 Impact Factor
Show more